An interventional study of Gunnar OTC Glasses in Dry Eye, Eye Strain and Visual Acuity, sponsored by Pacific University. Terminated at 1 site in United States. Open to participants aged 18 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-16.
Sponsored by Pacific University · Not applicable, Interventional, and Other
The proposed study aims to test if Gunnar computer glasses provide any advantages, in comparison to no glasses, on the following aspects in computer-related office work:
\<Introduction>
When performing near work, one must focus at (accommodate) and point toward (converge) at a closer distance and constantly re-focus the eyes to see small text and images with clarity. Sustaining such efforts can lead to eye fatigue and eye strain, among a host of vision problems. Most visual tasks on a screen also demand heightened visual concentration, and this decreases blink rate. Working in a heated or air-conditioned office environment leads to over-evaporation of the tear film, and lipid deficiency, irritation, and dryness to the corneal surface are expected. Disruptive glare from excessive screen reflection and ambient lighting also deteriorates the image quality and heaps on viewing discomfort. Extensive screen viewing also exacerbates discomfort in people with existing vision problems like eye muscle imbalance, astigmatism, farsightedness, and presbyopia. Since technology is almost unavoidable to modern life, preventions should be taken to lessen the total toll on the eyes and visual system. Gunnar computer glasses address the above issues by providing mild yellow tint anti-reflection coating to shield the harmful blue light and lessen strong glare. The glasses also have a small amount of magnification (+0.5 D) to enhance acuity. The curved frame is designed to retain moisture and reduce dry eye symptoms. All these special characters are devised to enhance visual performance and minimize eye fatigue and visual discomfort in digital viewing. The current study aimed to validate the benefits mentioned above.
Gunnar over-the-counter (OTC) computer glasses adopt yellow lenses to cut off the active short wavelength and lessen the bright glare, which often induces the detrimental effect caused by excessive illumination or intense scattered reflection. While the benefit of glare reduction is well received, the benefit on visual performance has been inconclusive. Some studies reported a significant enhancement in contrast sensitivity, but some failed to see any improvement in visual acuity and contrast sensitivity, even with color distortion. Without argument, tinted lenses reduce the transmittance of the visible spectrum and change the visible color to a certain degree. However, there has been a report that reducing the retinal illumination level does not necessarily lead to reduced brightness; instead, the visual system automatically adjusts for the illumination discounting, possibly with the help of increased pupil size. In addition, with the decrement of blue lights arriving at the eyes, both scattered reflection and chromatic aberration are reduced. Together, it is reasonable to believe that the visual acuity, contrast sensitivity, and chromatic discrimination will not suffer and may, instead, benefit from the filter of yellow lenses. These basic visual functions may, in turn, lead to enhancement in general visual performance such as routine office work. These will be tested in the proposed study.
The current study tested if Gunnar's OTC computer glasses provide any advantages, in comparison to no glasses, on the following aspects in computer-related office work:
\<Study design>
Thirty-four subjects, age 18 to 42, were planned to be recruited. This sample size is based on a priori power analysis with 80% and a medium effect size at alpha equal to 0.05. Subjects will be stratified into four age groups. An about equal number (8±1) of subjects should have been recruited for each group:
Each subject was scheduled for three visits: Visit 1 for screening and consenting, visit 2 for lab test after treatment 1, and visit 3 for lab test after treatment 2. Between visits was an adaptation period for the assigned treatment.
Visit 1: A screening visit
Adaptation 1:
- Starting on Day 1, for 3 to 7 days, the subject was asked to work in front of computers for at least 4 hours each day with assigned treatment 1.
Visit 2: Lab test for treatment 1
Adaptation 2 with treatment 2:
- Starting on the day of Visit 2 after the test, the subject adapts to the second treatment (with Gunnar glasses or without any glasses) for another 3 to 7 days.
Visit 3: Lab test for treatment 2
Details of lab testing procedures:
The study adopted a crossover design. Each subject went through three viewing conditions (control, bright light, strong ventilating) based on a Latin Square order.
In the strong ventilation condition, a ceiling fan will be positioned on top of the subject at the ceiling light location to increase the airflow.
Visual performance tasks:
Under viewing condition 1:
1,366 studies on the registry are indexed under Dry Eye Syndromes; 207 are open to participants now.
This study's enrollment of 35 is below the median of 60 across 1,129 interventional studies indexed under Dry Eye Syndromes.
Browse Dry Eye Syndromes studies →Pacific University is the lead sponsor of 14 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
On Visit 1, after the screening and baseline measurements, participants were given a pair of Gunnar OTC glasses (Intervention 1) and asked to work on the computer with the glasses for at least 4 hours for 5+/-2 days of adaptation (Habituation 1). On Visit 2, they performed the designated computer tasks with the glasses to complete the Gunnar condition. Then they were asked to work on the computers for at least 4 hours without any glasses (Intervention 2) for another 5+/-2 days (Habituation 2). On Visit 3, they performed the same tasks without any glasses to complete the Control condition. Then Participants responded if they prefer wearing the Gunnar OTC Glasses when working on a computer.
Device: Gunnar OTC Glasses
On Visit 1, after the screening and baseline measurements, participants were told to work on the computer for at least 4 hours without glasses (Intervention 1) for 5+/-2 days of adaptation (Habituation 1). On Visit 2, they performed the designated computer tasks without glasses to complete the Control condition. Then they were given a pair of Gunnar OTC Glasses to wear (Intervention 2) while working on the computers for 4+ hours daily for another 5+/-2 days (Habituation 2). On Visit 3, they performed the same tasks with the Gunnar glasses to complete the Gunnar condition. Then Participants responded if they prefer wearing the Gunnar OTC Glasses when working on a computer.
Device: Gunnar OTC Glasses
Gunnar Over-the-Counter Computer Glasses have optical power of 0.5 diopters for reducing accommodation demands at a typical computer-viewing distance. The lens also have a partially transmissive yellow tinting and anti-reflective coating for filtering part of the spectral peaks in typical fluorescent or incandescent light. The frame has a wrape-around design meant to reduce air flow in the vicinity of the eyes.
Subjective Rating of Gunnar Computer Glasses Preference
At the end of the study in Visit 3, subjects were asked to respond if they felt the Gunnar TC Glasses improved their computer viewing comfort and visual performance (choose between "Yes" and "No").
Time frame: at the end of the study in Visit 3, up to day 16
Subjective Viewing Discomfort Rating
Subjective rating of viewing comfort on the Viewing Symptom Survey (15 items, 5-pt Likert scale, 0: no discomfort; 4: extremely discomfort). Factor Analysis reduced the information dimension from 15 items to 5 factors: 1. Decreased cognitive function: sleepy, can't concentrate, can't think clearly, difficulty to remember 2. Eyestrain: eye strain, tired eyes 3. Physical discomfort: body discomfort, neckache, headache 4. Decreased visual function: blurry, double vision, can't focus, moving text 5. Poor balance: vertigo, dizzy A factor score is a linear transformation of the variables with weights. Its unit is arbitrary and meaningless; no min or max. However, as the values (correlation between variable and factor) in the Structure Matrix are positive, the sign of the factor is the same as the variables. Positive larger values mean more discomfort. A linear mixed model compares the relative impact of the interventions (Gunnar OTC glasses vs. Control\_No glasses) on each factor.
Time frame: Data were collected at the end of Visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and Visit 3 (at least 3 days after Visit 2, up to Day 16).
Visual Acuity
The participant's ability to identify high-contrast objects was measured in Visits 2 and 3. Measurements were recorded in the logarithmic Measure of Angle of Resolution (logMAR) scale, in which each 'line' of the symbols on a vision chart corresponds to a unit of 0.1 and represents a 10-fold difference in acuity compared to the adjacent line of the vision. Normal (6/6 or 20/20) vision in Snellen notation equals 0.0 logMAR (logarithmic of 1.0 arc minute or 1/60 of a degree). A negative logMAR value means better than normal (20/20) vision, and a smaller logMAR represents better vision in distinguishing finer details.
Time frame: during Visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and Visit 3 (at least 3 days after Visit 2, up to Day 16)
Color Perception
Participants' best performance in discriminating the number of color saturation levels was measured during visits 2 and 3. In each trial, six circles of the same color in 1-6 shades were presented. Participants responded with the number of color shades presented. Four colors (red, green, blue, and gray) were tested and analyzed separately. Performance in gray was used as the covariate for analysis.
Time frame: during Visit 2 (at leadays after Visit 1, between Day 4 and Day 8) and Visit 3 (at least 3 days after Visit 2, up to Day 16)
Spelling Check Accuracy
subject's accuracy in spelling check.
Time frame: Performance was measured during visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and visit 3 (at least 3 days after Visit 2, up to Day 16).
Dry Eye Measurements (1): Tear Film Break-up Time (Seconds)
Tear film break-up time (TBUT) measures the duration the tear covers the cornea surface fully until it evaporates. It reflects the stability of the tear film and is commonly used in clinics to check for evaporative dry eye syndrome. In testing for TBUT, sodium fluorescein dye is added to the eye, and the tear film is observed under the slit lamp while the patient avoids blinking until tiny dry spots develop. Larger numbers mean the tear stays on the cornea surface longer and is less severe for dry eye symptoms. Usually, TBUT values range from 3-132 seconds (average 27 seconds). TBUT less than 10 seconds suggests an abnormal tear film, 5-10 seconds considered marginal, and less than 5 seconds indicative of dry eye.
Time frame: during Visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and Visit 3 (at least 3 days after Visit 2, upto Day 16)
Contrast Sensitivity
The participant's ability to identify low-contrast objects was measured in Visits 2 and 3. A letter contrast sensitivity test by M\&S Technology measures the subject's ability to detect objects without a clear outline and distinguish them from their background. The M\&S Letter Contrast Sensitivity Test uses standard Snellen and Sloan Letters presented at contrast levels from 100% to 0.8%, with smaller numbers indicating better performance (better contrast sensitivity).
Time frame: during Visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and Visit 3 (at least 3 days after Visit 2, up to Day 16)
Spelling Check Speed (Words Per Minute, WPM)
This measures the subject's speed (words per minute) in spelling check. Higher values mean better performance or more words being checked within one minute.
Time frame: Performance was measured during visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and visit 3 (at least 3 days after Visit 2, up to Day 16).
Dry Eye Measurements 2: Tear Osmolarity Index Measured With TearLab
Tear osmolarity measures the number of milliosmoles of the solutes (e.g., salt) per liter (mOsm/L) of tear. Normal values range from 275 to 295 mOsm/L. Higher values indicate higher concentrations of electrolytes in the tear, which reflect worse dry eye conditions. A diagnosis of dry eye syndrome is made if the osmolarity of either eye is larger than 308 mOsm/L, or when the difference in measured osmolarity between eyes is \>8 mOsmol/L
Time frame: during Visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and Visit 3 (at least 3 days after Visit 2, upto Day 16)
Dry Eye Measurements (3): Rating of the Corneal Integrity With Lissamine Green Staining (0-4, Lower is Better)
A score on a scale (0-4, lower number indicating a better, healthier cornea); A subjective grade on the Corneal Integrity Rating with Lissamine Green Evaluation Form, which is a clinical grading system used to assess the health and integrity of the corneal surface, particularly focusing on ocular surface damage, dryness, or irritation. It has 5 levels (0-4), with lower numbers being better. Here is the description of each level: 0: No staining; corneal surface completely intact, no signs of damage. Best possible score. 1. Minimal staining; few scattered dots of stain, very mild damage or dryness. 2. Moderate staining; more noticeable punctate staining but no confluent areas. 3. Marked staining; numerous punctate stains, possible small areas of confluent staining. 4. Severe staining; large confluent areas of stain, significant epithelial damage. Worst score.
Time frame: during Visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and Visit 3 (at least 3 days after Visit 2, upto Day 16)
Dry Eye Measurements (4): Blink Duration (Milliseconds) Measured Through Real-time Blink-contingent Visual Acuity Task
While the subject detected the orientation of a tumbling E, we measured the average interval between two blinks. Larger numbers mean a longer duration of a blink sustained.
Time frame: during Visit 2 (at least 3 days after Visit 1, between Day 4 and Day 8) and Visit 3 (at least 3 days after Visit 2, upto Day 16)
35 participants were screened and enrolled between June 28, 2013 and September 30th, 2013 in the Vision Performance Institute research lab in Scott Hall 129 at Pacific University Forest Grove Campus.
| Milestone | Gunnar OTC Glasses, Then Control | Control, Then Gunnar OTC Glasses |
|---|---|---|
| Started | 17 | 18 |
| Completed | 17 | 18 |
| Not completed | 0 | 0 |
| Milestone | Gunnar OTC Glasses, Then Control | Control, Then Gunnar OTC Glasses |
|---|---|---|
| Started | 17 | 18 |
| Completed | 17 | 18 |
| Not completed | 0 | 0 |
| Milestone | Gunnar OTC Glasses, Then Control | Control, Then Gunnar OTC Glasses |
|---|---|---|
| Started | 17 | 18 |
| Completed | 17 | 18 |
| Not completed | 0 | 0 |
| Milestone | Gunnar OTC Glasses, Then Control | Control, Then Gunnar OTC Glasses |
|---|---|---|
| Started | 17 | 18 |
| Completed | 17 | 18 |
| Not completed | 0 | 0 |
| Milestone | Gunnar OTC Glasses, Then Control | Control, Then Gunnar OTC Glasses |
|---|---|---|
| Started | 17 | 18 |
| Completed | 17 | 18 |
| Not completed | 0 | 0 |
At the end of the study in Visit 3, subjects were asked to respond if they felt the Gunnar TC Glasses improved their computer viewing comfort and visual performance (choose between "Yes" and "No").
| Participants | Age Group 1 (18-23 yo) | Age Group 2 (24-29 yo) | Age Grup 3 (30-35 yo) | Age Group 4 (36-42 yo) |
|---|---|---|---|---|
| Participant response : Yes | 6 | 7 | 8 | 9 |
| Participant response : No | 3 | 2 | 0 | 0 |
Subjective rating of viewing comfort on the Viewing Symptom Survey (15 items, 5-pt Likert scale, 0: no discomfort; 4: extremely discomfort). Factor Analysis reduced the information dimension from 15 items to 5 factors: 1. Decreased cognitive function: sleepy, can't concentrate, can't think clearly, difficulty to remember 2. Eyestrain: eye strain, tired eyes 3. Physical discomfort: body discomfort, neckache, headache 4. Decreased visual function: blurry, double vision, can't focus, moving text 5. Poor balance: vertigo, dizzy A factor score is a linear transformation of the variables with weights. Its unit is arbitrary and meaningless; no min or max. However, as the values (correlation between variable and factor) in the Structure Matrix are positive, the sign of the factor is the same as the variables. Positive larger values mean more discomfort. A linear mixed model compares the relative impact of the interventions (Gunnar OTC glasses vs. Control\_No glasses) on each factor.
| factor score | Gunnar OTC Glasses | Control |
|---|---|---|
| Decreased cognitive function | -0.128 ± 0.109 | 0.154 ± 0.111 |
| Eyestrain | -0.228 ± 0.099 | 0.239 ± 0.101 |
| Physical discomfort | 0.132 ± 0.114 | -0.117 ± 0.115 |
| Decreased visual function | -0.187 ± 0.115 | 0.197 ± 0.117 |
| Poor balance | -0.107 ± 0.112 | 0.109 ± 0.113 |
The participant's ability to identify high-contrast objects was measured in Visits 2 and 3. Measurements were recorded in the logarithmic Measure of Angle of Resolution (logMAR) scale, in which each 'line' of the symbols on a vision chart corresponds to a unit of 0.1 and represents a 10-fold difference in acuity compared to the adjacent line of the vision. Normal (6/6 or 20/20) vision in Snellen notation equals 0.0 logMAR (logarithmic of 1.0 arc minute or 1/60 of a degree). A negative logMAR value means better than normal (20/20) vision, and a smaller logMAR represents better vision in distinguishing finer details.
| logMAR | Gunnar OTC Glasses | Control |
|---|---|---|
| Visual Acuity | -0.474 ± 0.002 | -.0474 ± 0.002 |
Participants' best performance in discriminating the number of color saturation levels was measured during visits 2 and 3. In each trial, six circles of the same color in 1-6 shades were presented. Participants responded with the number of color shades presented. Four colors (red, green, blue, and gray) were tested and analyzed separately. Performance in gray was used as the covariate for analysis.
| color saturation shades | Gunnar OTC Glasses | Control |
|---|---|---|
| Red | 2.952 ± 0.059 | 3.102 ± 0.059 |
| Green | 2.935 ± 0.046 | 2.887 ± 0.045 |
| Blue | 3.404 ± 0.075 | 3.399 ± 0.075 |
| Gray | 5.320 ± 0.961 | 5.000 ± 0.962 |
subject's accuracy in spelling check.
| percentage of accuracy | Gunnar OTC Glasses | Control |
|---|---|---|
| Spelling Check Accuracy | .778 ± .029 | .812 ± .029 |
Tear film break-up time (TBUT) measures the duration the tear covers the cornea surface fully until it evaporates. It reflects the stability of the tear film and is commonly used in clinics to check for evaporative dry eye syndrome. In testing for TBUT, sodium fluorescein dye is added to the eye, and the tear film is observed under the slit lamp while the patient avoids blinking until tiny dry spots develop. Larger numbers mean the tear stays on the cornea surface longer and is less severe for dry eye symptoms. Usually, TBUT values range from 3-132 seconds (average 27 seconds). TBUT less than 10 seconds suggests an abnormal tear film, 5-10 seconds considered marginal, and less than 5 seconds indicative of dry eye.
| seconds | Gunnar OTC Glasses | Control |
|---|---|---|
| Dry Eye Measurements (1): Tear Film Break-up Time (Seconds) | 6.018 ± 0.347 | 6.438 ± 0.336 |
The participant's ability to identify low-contrast objects was measured in Visits 2 and 3. A letter contrast sensitivity test by M\&S Technology measures the subject's ability to detect objects without a clear outline and distinguish them from their background. The M\&S Letter Contrast Sensitivity Test uses standard Snellen and Sloan Letters presented at contrast levels from 100% to 0.8%, with smaller numbers indicating better performance (better contrast sensitivity).
| contrast ratio expressed in "%" | Gunnar OTC Glasses | Control |
|---|---|---|
| Contrast Sensitivity | 1.115 ± 0.024 | 1.145 ± 0.024 |
This measures the subject's speed (words per minute) in spelling check. Higher values mean better performance or more words being checked within one minute.
| words per minute | Gunnar OTC Glasses | Control |
|---|---|---|
| Spelling Check Speed (Words Per Minute, WPM) | 178.892 ± 7.427 | 183.319 ± 7.285 |
Tear osmolarity measures the number of milliosmoles of the solutes (e.g., salt) per liter (mOsm/L) of tear. Normal values range from 275 to 295 mOsm/L. Higher values indicate higher concentrations of electrolytes in the tear, which reflect worse dry eye conditions. A diagnosis of dry eye syndrome is made if the osmolarity of either eye is larger than 308 mOsm/L, or when the difference in measured osmolarity between eyes is \>8 mOsmol/L
| mOsm/L (milliosmoles per liter) | Gunnar OTC Glasses | Control |
|---|---|---|
| Dry Eye Measurements 2: Tear Osmolarity Index Measured With TearLab | 302.789 ± 1.257 | 303.043 ± 1.257 |
A score on a scale (0-4, lower number indicating a better, healthier cornea); A subjective grade on the Corneal Integrity Rating with Lissamine Green Evaluation Form, which is a clinical grading system used to assess the health and integrity of the corneal surface, particularly focusing on ocular surface damage, dryness, or irritation. It has 5 levels (0-4), with lower numbers being better. Here is the description of each level: 0: No staining; corneal surface completely intact, no signs of damage. Best possible score. 1. Minimal staining; few scattered dots of stain, very mild damage or dryness. 2. Moderate staining; more noticeable punctate staining but no confluent areas. 3. Marked staining; numerous punctate stains, possible small areas of confluent staining. 4. Severe staining; large confluent areas of stain, significant epithelial damage. Worst score.
| score on a scale | Gunnar OTC Glasses | Control |
|---|---|---|
| Dry Eye Measurements (3): Rating of the Corneal Integrity With Lissamine Green Staining (0-4, Lower is Better) | 2.633 ± 0.121 | 3.025 ± 0.125 |
While the subject detected the orientation of a tumbling E, we measured the average interval between two blinks. Larger numbers mean a longer duration of a blink sustained.
| milliseconds | Gunnar OTC Glasses | Control |
|---|---|---|
| Dry Eye Measurements (4): Blink Duration (Milliseconds) Measured Through Real-time Blink-contingent Visual Acuity Task | 3536.468 ± 222.0143 | 3514.788 ± 222.0143 |
Collected over Each subject visited the lab three times: for about 30-40 minutes on visit 1 and about 4 hours each on visits 2 and 3. The adverse events were monitored while the subject was participating in the study for up to 16 days.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Gunnar OTC Glasses | 0/35 (0%) | 0/35 (0%) | 0/35 (0%) |
| Control | 0/35 (0%) | 0/35 (0%) | 0/35 (0%) |
| Age, Categorical(Participants) | Gunnar OTC Glasses, Then Control | Control, Then Gunnar OTC Glasses | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 17 | 18 | 35 |
| >=65 years | 0 | 0 | 0 |
| Sex: Female, Male(Participants) | Gunnar OTC Glasses, Then Control | Control, Then Gunnar OTC Glasses | Total |
|---|---|---|---|
| Female | 8 | 6 | 14 |
| Male | 9 | 12 | 21 |
| Race and Ethnicity Not Collected(Participants) | Gunnar OTC Glasses, Then Control | Control, Then Gunnar OTC Glasses | Total |
|---|---|---|---|
| Count of participants | — | — | 0 |
Plan to share: No — There is not a plan to make IPD available.
The record gives a start of Jun 2013, a primary completion of Sep 2013 and a completion of Sep 2013. It does not say whether these dates are actual or estimated.
Results were first posted in Jul 2025, 11 years 10 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pacific University